Resistance to fusidic acid

International Journal of Antimicrobial Agents

Volumn 12, Issue SUPPL. 2, 1999, Pages

  Turnidge, John ^a   Collignon, Peter ^b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b NONE

Author keywords

Elongation; Factor G; Resistance; Staphylococcus aureus

Indexed keywords

ELONGATION FACTOR; ELONGATION FACTOR G; FUSIDIC ACID;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CROSS INFECTION; DRUG RESISTANCE; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; R FACTOR; REVIEW; STAPHYLOCOCCUS AUREUS;

EID: 0032839672     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(98)00072-7     Document Type: Article

References (92)

1. Sinden D., Chopra I. Fusidic acid resistance in Staphylococcus aureus. Jeljaszewicz J. Staphylococci and Staphylococcal Infections: Proceedings of the IV International Symposium on Staphylococci and Staphylococcal Infections, Warszawa 1979. 1981;1981 Gustav Fischer Verlag, Stuttgarrt.
2. Russell A.D. Microbial Cell walls and resistance of bacteria and fungi to antibiotics and biocides. J. Infect. Dis. 168:1993;1339-1340.
3. Noble W.C., Naidoo J. Evolution of antibiotic resistance in Staphylococcus aureus: the role of the skin. Br. J. Dermatol. 98:1978;481-489.
4. Lacey R.W., Grinstead J. Linkage of fusidic acid resistance to the penicillinase plasmid in Staphyococcus aureus. J. Gen. Microbiol. 83:1974;375-387.
5. Chopra I. Mechanisms of resistance to fusidic acid in Staphylococcus aureus. J. Gen. Microbiol. 96:1976;229-238.
6. Shanson D.C. Clinical relevance of resistance to fusidic acid in Staphylococcus aureus. J. Antimicrob. Chemother. 25:1990;7-14.
7. Richter Dahlfors A.A., Kurland C.G. Novel mutants of elongation factor G. J. Mol. Biol. 20:1990;549-557.
8. Tanaka N., Kawano G., Kinoshita T. Chromosomal location of a fusidic acid resistance marker in Escherichia coli. Biochem. Biopnys. Res. Comm. 42:1971;564-567.
9. Johanson U., Hughes D. Fusidic acid-resistant mutants define three regions in elongation factor G of Salmonella typhimurium. Gene. 143:1994;55-59.
10. Fung-Tomc J., Kolek B., Bonner D.P. Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus. Antimicrob. Agents. Chemother. 37:1993;1289-1296.
11. Verbist L. The antimicrobial activity of fusidic acid. J. Antimicrob. Chemother. 25:1990;7-14.
12. O'Grady F., Greenwood D. Interactions between fusidic acid and penicillins. J. Med. Microbiol. 6:1973;441-450.
13. Evans R.J., Waterworth P.M. Naturally-occurring fusidic acid resistance in staphylococci and its linkage to other resistnaces. J. Clin. Pathol. 19:1955;555-560.
14. Lacey R.W., Rosdahl V.T. An unusual jpenicillinase plasmid in Staphylococcus aureus; evidence for its transfer under natural conditions. J. Med. Microbiol. 7:1974;117-125.
15. Marcoli R., Iida S., Bickle T.A. The DNA sequence of an IS/-flanked trasposon encoding for resistance to chloramphenicol and fusidic acid. FEBS. Lett. 110:1980;11-14.
16. Murray I.A., Cann P.A., Day P.J., Derrick J.P., Sutcliffe M.J., Shaw W.V., Leslie A.G. Steroid recognition by choramphenicol acteyltransferase: engineering and structural analysis of a high affinity fusidic acid binding site. J. Mol. Biol. 254:1995;993-1005.
17. Bennett A.D., Shaw W.V. Resistance to fusidic acid in Escherchia coli mediated by the type I variant of chloramphenico acetyltransferase. A plasmid-encoded mechanism involving antibiotic binding. Biochem. J. 215:1983;29-38.
18. Proctor G.N., McKell J., Rownd R.H. Chloramphenicol acetyltransferase may confer resistance to fusidic acid by sequestering the drug. J. Bacteriol. 155:1983;937-939.
19. Völker T.A., Iida S., Bickle T.A. A single gene coding for resistance to both fusidic acid and chloramphenicol. J. Mol. Biol. 154:1982;417-425.
20. von der Haar B., Rosenberg D., Dittrich W., Scxhrempf H. Inactivation of fusidic acid by resistant Streptomyces strains. J. Antibiot. (Tokyo). 44:1991;785-792.
21. Lacey R.W., Richmond M.H. The genetic basis of antibiotic resistance in S. aureus: the importance of gene transfer in the evolution of this organism in the hospital environment. Ann. NY. Acad. Sci. 236:1974;395-412.
22. Lacey R.W., Lewis E., Rosdahl V.T. Evolution of plasmids in vivo in a strain of Staphylococus aureus. J. Med. Microbiol. 7:1974;117-125.
23. Datta N., Hedges R.W., Becker D., Davies J. Plasmid-mediated resistance to the penicillinase plasmid in the Enterobacteriacease. J. Gen. Microbio. 83:1974;191-196.
24. Roser H. Determination of resistance to the antibiotic staphylomycin. Med. Klin. 61:1966;919-921.
25. Legler F. Present resistance status of Staphylococcus aureus under specific consideration of the antibiotics virgimycin, cephalothin and fusidic acid. Arzneimittelforschung. 17:1967;1523-1525.
26. Roser H. Resistance of Staphylococcus aureus to Fucidin since 1970 compared to other effective antibacterial substances. Munch Med Wochensch 1974;116:1849-52.
27. Kobayashi M., Yamamoto S., Takami H., Mihara K. Sensitivity test of clinical isolates to fusidic acid. Jpn. J. Antibiot. 24:1971;152-155.
28. Pulverer G. Actual medical importance and antibiotic resistance of staphylococci. Dtsch. Med. Wochenschr. 97:1972;252-254.
29. Lemeland J.F., Boiron H. A profile of bacterial resistance in the University Hospital of Rouen (July 72 to June 73). Ouest. Med. 27:1974;1803-1806.
30. Lemeland J.F., Jouet F., Boiron H. Assessment of the activity of gentamicin against 17,123 microbial strains isolated at the University Hospital of Rouen during a 2 year period. Quest. Med. 28:1975;879-883.
31. Lacey R.W., Keyworth N., Lincoln C. Staphylocci in the UK: a review. J. Antimicrob. Chemother. 14:1984;19-25.
32. Varaldo P.E., Cipriani P., Foca A., Geraci C., Giordano A., Madeddu M.A., Orsi A., Pompei R., Prenna M., Repeeto A., Ripa S., Rosselli P., Russo G., Scazzochio F., Stassi G. Identification, clinical distribution, and susceptibility to methicillin and 18 additional antibiotics of clinical Staphylococcus isolates: nationwide investigation in Italy. J. Clin. Microbiol. 19:1984;838-843.
33. Millar M.R., Griffin N., Keyworth N. Pattern of antibiotic and heavy-metal ion resistance in recent hospital isolates of Staphylococcus aureus. Epidemiol. Infect. 99:1987;343-347.
34. Cookson B.D., Lacey R.W., Noble W.C., Reeves D.S., Wise R., Redhead R.J. Mupirocin-resistant Staphylococcus aureus. Lancet. 335:1990;1095-1096.
35. Moorhouse E., Fenelon L., Hone R., Smyth E., McGahon J., Dillon M. Staphylococcus aureus sensitivity to various antibiotics - a national survey in Ireland 1993. Ir. J. Med. Sci. 165:1996;40-43.
36. Toma E., Barriault D. Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci. J. Clin. Microbiol. 33:1995;1712-1715.
37. Faber M., Rosdahl V.T. Susceptibility ot fusidic acid among Danish Staphylococcus aureus strains and fusidic acid consumption. J. Antimicrob. Chemother. 25:1990;7-14.
38. Gransden W.R., Eykyn S.J., Phillips I. Staphylococcus aureus bacteraemis: 400 episodes in St. Thomas's Hospital. Br. Med. J. (Clin. Res. Ed). 288:1984;300-303.
39. Speller D.C.E., Johnson A.P., James D., Marples R.R., Charlett A., George R.C. Resistance to methicillin and other antibiotics is isolates of Staphylococcus aureus from blood and cerebrospinal fluid. England and Wales 1989-95. Lancet. 350:1997;323-325.
40. Ashkenazi S., Leibovici L., Churi C., Konigsberger H., Drucker M., Samra Z. Childhood bacteraemia in Israel: antibiotic susceptibility profiles. Int. Paed. 9:1994;8-14.
41. Thomsen M. The Burns Unit in Copenhagen. 10. Antibiotic sensitivity of Staphylococcus areus isolated from burns. Acta. Pathol. Microbiol. Scand. (B) Microbiol. Immunol. 79:1971;314-324.
42. Ayliffe G.A., Green W., Livingston R., Lowbury E.J. Antibiotic-resistant Staphylococcus aureus in dermatology and burn wards. J. Clin. Pathol. 30:1977;40-44.
43. MacFarlane T.W., McGill J.C., Samaranayake L.P. Antibiotic sensitivity and phage typing of staphylococcus aureus isolated from non-hospitalized patients with angular cheilitis. J. Hosp. Infect. 5:1984;444-446.
44. Gillett A.P., Johnson T., Orton C., Wills R., Menday A.P., Talbot D.J. Nasal carriage and antibiotic susceptibility of Staphylococcus aureus in general practice. J. R. Coll. Gen. Pract. 34:1984;255-257.
45. Martín de Nicolás M.M., Vindel A., Torrellas A., Sáez-Nieto J.A. In vitro activity of mupirocin and eleven other antibiotics against 1500 clinical isolates of Staphylococcus aureus causing hospital infections. Rev. Esp. Quimioterap. 8:1995;145-150.
46. Veselov A.ya Micorflora of purulent inflammatory foci in surgical patients and its antibiotic sensitivity. Antibiotiki. I. Khimiotherapiia. 35:1990;40-43.
47. Lelong M, Folaert J, Deroubaix P, Derambure S, Sorez JP, Vanlaeys R, Thelliez P, Hogedez G. Antibiotic resistance of Staphylococcus aureus isolated from children. Comparative evolution between 1967 and 1972. Lille Med 1973;18:433-437.
48. Marschang A. Antibacterial sensitivity and resistance profiles from 1979 to 1981 in the intensive care department. Krankenhausarzt 1983;56:46-52.
49. Andersen B.M., Lossius H.A. Staphylococci in Northern Norway. In vitro identification and antimicrobial resistance patterns. Tidsskrift. for. Den. Norske. Laegeforening. 109:1989;49-52.
50. Turnidge J.D., Nimmo G.R., Francis G. Evolution of resistance in Staphylococcus aureus in Australian teaching hospitals. Med. J. Aust. 164:1996;68-71.
51. Verbist L. The antimicrobial activity of fusidic acid. J. Antimicrob. Chemother. 25((Suppl B)):1990;1-5.
52. Jensen K.T., Scheel O. Resistance to antibiotics in Gram-positive bacteria from blood cultures. Ugeskr. Laerer. 150:1988;3056-3058.
53. Speranskaia O.N., Fomina T.P., Kuznetsova S.M. Methicillin-resistant staphylococci: biological properties and sensitivities to antibiotics. Antibiotiki. 18:1973;62-68.
54. Reverdy M.E., Bes M., Brun Y., Fleurette J. Evolution of antibiotic and antiseptic resistance of hospital Staphylococcus aureus strains isolated from 1980 to 1991. Path. Biol. 41:1993;897-904.
55. Reeves D.S., Holt H.A., Phillips I., King A., Miles R.S., Paton R., Wise R., Andrews J.M. Activity of clindamycin against Staphylococcus aureus and Staphylococcus epidermidis from four UK centres. J. Antimicrob. Chemother. 27:1991;469-474.
56. Kanazaki H., Akiyama H., Kanamoto A., Abe Y., Yamada T., Arata J., Umemura S., Ikeda M. Outburst of fusidic acid resistant Staphylococcus aureus. Jpn. J. Dermatol. 99:1989;507-510.
57. Skjerven O., Melby K., Dramsdahl H., Alvestad P.M. Staphylococcal infections among newborn babies in two towns in north Norway. NIPH. Ann. 5:1982;51-56.
58. Borowski J, Jacubicz P, Zaremba M et al. Nationwide studies on ocurrence of methicillin resistant Staphylococcus aureus and Staphylococcus coagulase-negative strains in Polish hospitals. First International Conference of the Hospital Infection Society, 1987.
59. Cheong I., Tan S.C., Wong Y.H., Zainudin B.M.Z., Rahman M.Z.A. Methicillin-resistant Staphylococcus aureus (MRSA) in a Malaysian teaching hospital. Med. J. Malaysia. 49:1994;24-28.
60. Gottlieb T., Mitchell D. on behalf of the Australian Group on Antimicrobial Resistance. J. Antimicrob. Chemother. 42:1998;67-73.
61. Smith J.A., Henry D.A., Bourgault A.M., Bryan L., Harding G.J., Hoban D.J., Horsman G.B., Marrie T., Turgeon P. Comparison of agar disk diffusion, microdilution broth and agar dilution for testing antimicrobial susceptibility of coagulase-negative staphylococci. J. Clin. Microbiol. 25:1987;1741-1746.
62. Petrevska-Sibinovska D. Some characteristics and susceptibility to antibiotics of clinically significant strains of coagulase-negative staphylococci. Giornale. di. Malattie. Infettive. e. Parasitarie. 42:1990;744-748.
63. Richardson J.F., Marples R.R. Changing resistance to antimicrobial drugs, and resistance typing in clinically significant strains of Staphylococcus epidermidis. J. Med. Microbiol. 15:1982;475-484.
64. Richardson J.F., Marples R.R. Differences in antibiotic susceptibility between Staphylococcus epidermidis and Staphylococcus saprophyticus. J. Antimicrob. Chemother. 6:1980;499-510.
65. Barber M., Waterworth P.M. Antibacterial activity in vitro of Fucidin. Lancet. 1:1962;931-932.
66. Taylor G., Bloor K. Antistaphylococcal activity of Fucicin. Lancet. 1:1962;935-937.
67. Godtfredsen W., Roholt K., Tybring L. Fucicin. A new orally active antibiotic. Lancet. 1:1962;928-931.
68. Jensen K.A., Kiaer I. Fucidin: a study on problems of resistance. Acta. Pathol. Microbiol. Scand. 60:1964;271-284.
69. Zygmunt W.A., Harrison E.F., Browder H.P., Tavormina P.A. Comparative inhibition of methicillin-resistant strains of Staphylococcus aureus by lysostaphin and other antibiotics. Appl. Microbiol. 16:1968;1174-1178.
70. Melchior NH. Combined in vitro activity of fusidic acid and rifampicin against methicillin-resistant: proceedings of the 14th International Congress of Chemotherapy, Kyoto, 1985. Tokyo: University of Tokyo Press, 1985:582-583.
71. Garrett E.R., Richard A.J. Kinetics and mechanisms of drug action on microorganisms XX: integrated receptor site model rationalizing observed mirobioal rate dependencies on drug concentration and microbial kinetics affected by sodium fusidate. J. Pharm. Sci. 63:1974;884-894.
72. Fantin B, Leclercq R, Duval J, Carbon D. Fusidic acid alone or in combination with vancomycin for the therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1993; 37:2466-9.
73. Lowbury E.J.L., Cason J.S., Jackson Dmac G., Miller R.W.S. Fucidin for staphylococcal infection of burns. Lancet. 2:1962;478-480.
74. Porter I.A., Wilson J.S.P. Staphylococcal infection treated with fusidic acid in nurses. Lancet. 2:1963;658-680.
75. Dineen P. Fusidate sodium in the treatment of surgical infections. Arch. Surg. 96:1968;219-221.
76. Schumer W., Abtahi H. Sodium fusidate in surgical wound infections. Am. J. Surg. 115:1968;527-530.
77. Lautenbach E.E.G., Robinson R.G., Koornhof H.J. Serum and tissue concentrations of sodium fusidate inpatients with chronic osteomyelitis and in normal volunteers. S. Afr. Surg. 13:1975;21-32.
78. Price E.H., Brain A., Dickson J.A. An outbreak of infection iwht a gentamicin and methicillin-resistant Staphylococcus aureus in a neonatal unit. J. Hosp. Infect. 1:1980;221-228.
79. Naidoo J., Noble W.C. Acquisition of antibiotic resistance by Staphylococcus aureus in skin patients. J. Clin. Pathol. 31:1978;1187-1192.
80. Shanson D.C. Antibiotic-resistant Staphylococcus aureus. J. Hosp. Infect. 2:1981;11-36.
81. Anon. Antibiotic resistance and topical treatment (editorial). Br Med J 1978;2:649-50.
82. Pattison J.R., Mansell P.E. Fucidin-resistant staphylococci in current hospital practice. J. Med. Microbiol. 6:1973;235-244.
83. Smith R.J., Alder V.G., Warin R.P. Pyogenic cocci in infantile eczema throughout one year. Br. Med. J. 3:1975;199-201.
84. Ayliffe G.A.J., Lilly H.A., Lowbury E.J.L. Decline of the hospital staphylococcus? Incidence of multiresistant Staph. aureus in three Birmingham hospital. Lancet. 1:1979;538-541.
85. Wilkinson J.D., Leigh D., Menday A.P. Comparative effciacy of betamethasone and either fusidic acid or neomycin in infected or potentially infected eczema. Curr. Ther. Res. 38:1985;177-182.
86. Ritchie IC. Economic aspects of surface sepsis: a trial of Fucicin ointment. Clin Trials J 1966;529-531.
87. Rowling D.E. Further experience in the management of chronic osteomyelitis. J. Bone. Joint. Surg. (Br). 52:1970;302-307.
88. Wright G.L.T., Harper J. Fusidic acid and lincomycin therapy in staphylococcal infections in cystic fibrosis. Lancet. 1:1970;1-14.
89. O'Brien T., McManus F., MacAuley P.H., Ennis J.T. Acute haematogenous osteomyelitis. J. Bone. Joint. Surg. (Br). 64:1982;450-453.
90. Learmonth I.D., Dall G., kPollock D.J. Antibiotic therapy in acute infections of bone and joints in children. S. Afr. Med. J. 65:1984;121-122.
91. Jensen K., Lassen H.C.A. Combined treatment with antibaterial chemotherapeutical agents in staphylococcal infections. Q. J. Med. 38:1969;91-106.
92. Jensen K. Mehticillin-resistant staphylococci. Lancet. 16:1968;1078.